Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Lohmann

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Neuro-Oncology Advances|September 29, 2025
Advancements in noninvasive visualization of the immune environment in glioblastoma: A systematic reviewPhilipp Lohmann, Laura Schäfer, Sandra Krause, et al.
Neuro-Oncology|January 14, 2024
Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitideChristina Maria Flies, Michel Friedrich, Philipp Lohmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2017
Static and dynamic <sup>18</sup>F-FET PET for the characterization of gliomas defined by IDH and 1p/19q statusAntoine Verger, Gabriele Stoffels, Elena K Bauer, et al.
Optics Express|September 23, 2025
Fast thermo-optic switching through parity-time symmetry breakingRavi Pradip, Akhil Varri, Liam McRae, et al.
Neuro-Oncology Advances|February 1, 2021
Feature-based PET/MRI radiomics in patients with brain tumorsPhilipp Lohmann, Anna-Katharina Meißner, Martin Kocher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 10, 2023
Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PETRobin Gutsche, Carsten Lowis, Karl Ziemons, et al.
Plos One|April 5, 2024
Impact of improved dead time correction on the quantification accuracy of a dedicated BrainPET scannerAhlam Said Mohamad Issa, Jürgen Scheins, Lutz Tellmann, et al.
Nuclear Medicine and Biology|March 2, 2020
Current trends in the use of O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine ([<sup>18</sup>F]FET) in neurooncologyCarina Stegmayr, Gabriele Stoffels, Christian Filß, et al.
Neuro-Oncology Advances|December 31, 2024
Evaluation of early metabolic changes following vorasidenib using FET PET in patients with <i>IDH</i>-mutant gliomasNorbert Galldiks, Jan-Michael Werner, Isabelle Stetter, et al.
Methods (San Diego, Calif.)|June 12, 2020
Radiomics in neuro-oncology: Basics, workflow, and applicationsPhilipp Lohmann, Norbert Galldiks, Martin Kocher, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Neuro-Oncology Advances|September 29, 2025
Advancements in noninvasive visualization of the immune environment in glioblastoma: A systematic reviewPhilipp Lohmann, Laura Schäfer, Sandra Krause, et al.
Neuro-Oncology|January 14, 2024
Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitideChristina Maria Flies, Michel Friedrich, Philipp Lohmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2017
Static and dynamic <sup>18</sup>F-FET PET for the characterization of gliomas defined by IDH and 1p/19q statusAntoine Verger, Gabriele Stoffels, Elena K Bauer, et al.
Optics Express|September 23, 2025
Fast thermo-optic switching through parity-time symmetry breakingRavi Pradip, Akhil Varri, Liam McRae, et al.
Neuro-Oncology Advances|February 1, 2021
Feature-based PET/MRI radiomics in patients with brain tumorsPhilipp Lohmann, Anna-Katharina Meißner, Martin Kocher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 10, 2023
Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PETRobin Gutsche, Carsten Lowis, Karl Ziemons, et al.
Plos One|April 5, 2024
Impact of improved dead time correction on the quantification accuracy of a dedicated BrainPET scannerAhlam Said Mohamad Issa, Jürgen Scheins, Lutz Tellmann, et al.
Nuclear Medicine and Biology|March 2, 2020
Current trends in the use of O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine ([<sup>18</sup>F]FET) in neurooncologyCarina Stegmayr, Gabriele Stoffels, Christian Filß, et al.
Neuro-Oncology Advances|December 31, 2024
Evaluation of early metabolic changes following vorasidenib using FET PET in patients with <i>IDH</i>-mutant gliomasNorbert Galldiks, Jan-Michael Werner, Isabelle Stetter, et al.
Methods (San Diego, Calif.)|June 12, 2020
Radiomics in neuro-oncology: Basics, workflow, and applicationsPhilipp Lohmann, Norbert Galldiks, Martin Kocher, et al.
Pageof 14